An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
about
Turbulent flow chromatography in bioanalysis: a review.Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry.Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors--review of assay methodologies and perspectives.An LC-MS/MS method for rapid and sensitive high-throughput simultaneous determination of various protein kinase inhibitors in human plasma.Clinical development of imatinib: an anticancer drug.Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS.Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.Mass spectrometry in leukemia research and treatment.Rugged and accurate quantitation of colchicine in human plasma to support colchicine poisoning monitoring by using turbulent-flow LC-MS/MS analysis.Antineoplastic drugs and their analysis: a state of the art review.Analysis of lignans in Magnoliae Flos by turbulent flow chromatography with online solid-phase extraction and high-performance liquid chromatography with tandem mass spectrometry.Therapeutic drug monitoring and tyrosine kinase inhibitors.Development and Validation of a Rapid RP-HPLC-DAD Analysis Method for the Simultaneous Quantitation of Paclitaxel and Lapatinib in a Polymeric Micelle Formulation.A Validated RP-HPLC Method for the Estimation of Lapatinib in Tablet Dosage form using Gemcitabine Hydrochloride as an Internal Standard.An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detection.Permeability analysis of neuroactive drugs through a dynamic microfluidic in vitro blood-brain barrier model.A validated UPLC-MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma.Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry.Development and Validation of Rapid Stability-Indicating RP-HPLC-DAD Method for the Quantification of Lapatinib and Mass Spectrometry Analysis of Degraded Products.Fast quantitative analysis of four tyrosine kinase inhibitors in different human plasma samples using three-way calibration-assisted liquid chromatography with diode array detection.
P2860
Q34317104-8F5283E4-9D3B-4D81-B5DC-53BE0F46695BQ34377463-388F32C8-0684-4ADA-B890-F89E85871B39Q34417423-E75D7F28-F131-4CB2-88B8-A11C5F8961A3Q35450340-325F5875-74E6-4A4A-BFA9-B6C7E54CFF85Q36083906-96EA205F-02C5-43E5-831F-A94E0772D1FCQ37474460-83853F09-1923-4014-9946-FD98DB0BF814Q38196297-1547D92F-B64A-4D02-B092-17163A961080Q38201503-585CC1D1-76AD-42E6-B383-E0F871ED8EE6Q38365432-E23399AE-C795-4BF9-8090-4B6C8DFC32ECQ39125092-1BE0FC9D-D1B5-475A-9194-1AB82050BB18Q39339684-6A4C8A15-48A5-45BA-935D-A5A2270B3463Q40034335-F97A4D96-9299-4BC8-9ACB-5F6A4304D0BAQ41846251-7CEE8499-330E-4F73-9D03-F8E6DDE023B5Q42094444-5B9D72B0-9F2E-4225-A944-707972EBA23BQ43120670-53484EB8-B2C5-4FE5-AEB2-B29113EA559DQ48122483-027ACBC4-E291-4752-8763-0A026E6F3A13Q48607094-22A4C300-3620-447C-A7F5-9BD084D2BAD0Q49473156-7CF72DD5-48EC-4F4B-8AC0-5E6A344A02F4Q50465014-19A1E91A-38AA-41B7-BD1D-C7DDC448547DQ53160975-CE38E10C-6F15-4E20-A7AC-C96F9C4DC98BQ53489856-E0DD68C4-564C-4315-88D4-564AF999EE16
P2860
An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An automated method for the me ...... aphy-tandem mass spectrometry.
@en
An automated method for the me ...... aphy-tandem mass spectrometry.
@nl
type
label
An automated method for the me ...... aphy-tandem mass spectrometry.
@en
An automated method for the me ...... aphy-tandem mass spectrometry.
@nl
prefLabel
An automated method for the me ...... aphy-tandem mass spectrometry.
@en
An automated method for the me ...... aphy-tandem mass spectrometry.
@nl
P2093
P2860
P1476
An automated method for the me ...... aphy-tandem mass spectrometry.
@en
P2093
A Corrigan
L Couchman
R J Flanagan
S Wickramasinghe
P2860
P2888
P304
P356
10.1007/S00216-012-5970-2
P407
P577
2012-04-14T00:00:00Z